Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance
Mental Health Disorders
About this trial
This is an interventional basic science trial for Mental Health Disorders focused on measuring cardiovascular disease, vascular function, PTSD, GAD
Eligibility Criteria
Inclusion Criteria:
- apparently healthy and free of overt cardiovascular, pulmonary, or metabolic disease
- for PTSD group, a score of ≥ 33 on PCL-5 checklist
- for GAD group, a score of ≥ 10 on the GAD-7 self-report scale
Exclusion Criteria:
- taking medications that could influence cardiovascular function
- limited English proficiency
Sites / Locations
- Virginia Commonwealth University
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Placebo Comparator
Experimental
Placebo Comparator
PTSD/GAD Antioxidant
PTSD/GAD Placebo
Healthy Control Antioxidant
Healthy Control Placebo
Subjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol).
Subjects will ingest placebo (microcrystalline cellulose) pills.
Subjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol).
Subjects will ingest placebo (microcrystalline cellulose) pills.